Geratherm Medical AG (GME.DE)
EUR 3.72
(2.76%)
EUR 3.72
(2.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.3 Million EUR | -18.93% |
| 2022 | 25.85 Million EUR | 4.92% |
| 2021 | 24.63 Million EUR | -10.29% |
| 2020 | 27.46 Million EUR | 38.36% |
| 2019 | 19.85 Million EUR | -7.76% |
| 2018 | 21.52 Million EUR | 2.34% |
| 2017 | 21.03 Million EUR | -4.68% |
| 2016 | 22.06 Million EUR | 2.2% |
| 2015 | 21.58 Million EUR | 15.36% |
| 2014 | 18.71 Million EUR | 9.9% |
| 2013 | 17.02 Million EUR | 4.6% |
| 2012 | 16.28 Million EUR | -14.23% |
| 2011 | 18.98 Million EUR | 6.74% |
| 2010 | 17.78 Million EUR | 19.23% |
| 2009 | 14.91 Million EUR | 38.94% |
| 2008 | 10.73 Million EUR | 21.96% |
| 2007 | 8.8 Million EUR | 2.47% |
| 2006 | 8.58 Million EUR | 1.54% |
| 2005 | 8.45 Million EUR | 9.37% |
| 2004 | 7.73 Million EUR | -0.29% |
| 2003 | 7.75 Million EUR | 7.06% |
| 2002 | 7.24 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 5.91 Million EUR | 0.0% |
| 2023 Q1 | 5.91 Million EUR | -28.28% |
| 2023 FY | 20.95 Million EUR | -18.93% |
| 2023 Q4 | 4.88 Million EUR | 0.0% |
| 2023 Q3 | 4.88 Million EUR | -17.31% |
| 2022 Q2 | 6.23 Million EUR | -5.06% |
| 2022 Q1 | 6.56 Million EUR | 15.59% |
| 2022 FY | 25.85 Million EUR | 4.92% |
| 2022 Q4 | 8.24 Million EUR | 28.77% |
| 2022 Q3 | 6.4 Million EUR | 2.68% |
| 2021 Q2 | 5.92 Million EUR | -13.77% |
| 2021 Q1 | 6.86 Million EUR | -10.91% |
| 2021 Q4 | 5.67 Million EUR | -7.97% |
| 2021 Q3 | 6.17 Million EUR | 4.24% |
| 2021 FY | 24.63 Million EUR | -10.29% |
| 2020 Q1 | 6.42 Million EUR | 42.68% |
| 2020 Q2 | 7.69 Million EUR | 19.79% |
| 2020 Q3 | 5.91 Million EUR | -23.19% |
| 2020 Q4 | 7.7 Million EUR | 30.39% |
| 2020 FY | 27.46 Million EUR | 38.36% |
| 2019 FY | 19.85 Million EUR | -7.76% |
| 2019 Q4 | 4.5 Million EUR | -3.03% |
| 2019 Q1 | 6.27 Million EUR | 6.49% |
| 2019 Q3 | 4.64 Million EUR | 1.27% |
| 2019 Q2 | 4.58 Million EUR | -26.94% |
| 2018 Q3 | 5.25 Million EUR | 2.79% |
| 2018 FY | 21.52 Million EUR | 2.34% |
| 2018 Q1 | 5.25 Million EUR | 10.13% |
| 2018 Q2 | 5.11 Million EUR | -2.77% |
| 2018 Q4 | 5.89 Million EUR | 12.14% |
| 2017 Q4 | 4.77 Million EUR | -7.95% |
| 2017 Q3 | 5.18 Million EUR | 6.32% |
| 2017 FY | 21.03 Million EUR | -4.68% |
| 2017 Q2 | 4.87 Million EUR | -21.16% |
| 2017 Q1 | 6.18 Million EUR | 8.33% |
| 2016 Q3 | 5.02 Million EUR | -14.85% |
| 2016 Q1 | 5.42 Million EUR | -4.35% |
| 2016 FY | 22.06 Million EUR | 2.2% |
| 2016 Q4 | 5.71 Million EUR | 13.74% |
| 2016 Q2 | 5.89 Million EUR | 8.68% |
| 2015 FY | 21.58 Million EUR | 15.36% |
| 2015 Q4 | 5.67 Million EUR | 7.89% |
| 2015 Q3 | 5.25 Million EUR | -0.84% |
| 2015 Q2 | 5.3 Million EUR | -0.86% |
| 2015 Q1 | 5.35 Million EUR | 31.09% |
| 2014 Q3 | 5.53 Million EUR | 8.38% |
| 2014 Q4 | 4.08 Million EUR | -26.29% |
| 2014 Q2 | 5.1 Million EUR | 28.13% |
| 2014 Q1 | 3.98 Million EUR | 4.54% |
| 2014 FY | 18.71 Million EUR | 9.9% |
| 2013 Q4 | 3.81 Million EUR | -12.55% |
| 2013 Q3 | 4.36 Million EUR | 0.85% |
| 2013 Q2 | 4.32 Million EUR | -4.62% |
| 2013 Q1 | 4.53 Million EUR | 5.5% |
| 2013 FY | 17.02 Million EUR | 4.6% |
| 2012 Q3 | 3.94 Million EUR | 2.13% |
| 2012 Q4 | 4.29 Million EUR | 8.99% |
| 2012 FY | 16.28 Million EUR | -14.23% |
| 2012 Q1 | 4.17 Million EUR | -22.05% |
| 2012 Q2 | 3.86 Million EUR | -7.61% |
| 2011 Q4 | 5.36 Million EUR | 10.7% |
| 2011 Q3 | 4.84 Million EUR | 24.5% |
| 2011 Q1 | 4.78 Million EUR | -68.79% |
| 2011 FY | 18.98 Million EUR | 6.74% |
| 2011 Q2 | 3.88 Million EUR | -18.64% |
| 2010 FY | 17.78 Million EUR | 19.23% |
| 2010 Q4 | 15.31 Million EUR | 242.99% |
| 2010 Q3 | 4.46 Million EUR | 2.22% |
| 2010 Q2 | 4.36 Million EUR | 10.39% |
| 2010 Q1 | 3.95 Million EUR | -16.95% |
| 2009 Q2 | 3.23 Million EUR | 3.85% |
| 2009 Q1 | 3.11 Million EUR | 0.0% |
| 2009 Q3 | 3.8 Million EUR | 17.64% |
| 2009 FY | 14.91 Million EUR | 38.94% |
| 2009 Q4 | 4.76 Million EUR | 25.34% |
| 2008 FY | 10.73 Million EUR | 21.96% |
| 2008 Q2 | 2.42 Million EUR | 0.0% |
| 2007 FY | 8.8 Million EUR | 2.47% |
| 2006 FY | 8.58 Million EUR | 1.54% |
| 2005 FY | 8.45 Million EUR | 9.37% |
| 2004 FY | 7.73 Million EUR | -0.29% |
| 2003 FY | 7.75 Million EUR | 7.06% |
| 2002 FY | 7.24 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| aap Implantate AG | 11.47 Million EUR | -94.292% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 99.339% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 99.339% |
| elexxion AG | 443.88 Thousand EUR | -4924.032% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 246.09 Million EUR | 90.938% |
| Koninklijke Philips N.V. | 18.16 Billion EUR | 99.877% |
| Stratec SE | 261.91 Million EUR | 91.485% |
| Siemens Healthineers AG | 22.36 Billion EUR | 99.9% |